Although elevated brain Aβ levels can be observed in many individuals without cognitive decline, tau protein accumulation is a more reliable indicator of cognitive deterioration and is strongly associated with Alzheimer’s disease (AD) diagnosis. Here, MAPT is linked to Alzheimer disease.